Yale University

EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library

School of Medicine

1974

Experimental immune fever; an in vitro study
Bruce Michael Markle
Yale University

Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
Recommended Citation
Markle, Bruce Michael, "Experimental immune fever; an in vitro study" (1974). Yale Medicine Thesis Digital Library. 2901.
http://elischolar.library.yale.edu/ymtdl/2901

This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.

ExDerimental Immune Fever:
An In Vitro Study

Bruce Michael Markle
B.A,,

1970 Brown University

A Thesis Presented to the Faculty of
Yale University School of Medicine
in
partial fulfillment of the requirements c
the degree of Doctor of Medicine

Yale University School of Medicine
Department of Infernal Medicine
New Haven,

Connecticut

March 1974

Digitized by the Internet Archive
in 2017 with funding from
The National Endowment for the Humanities and the Arcadia Fund

https://archive.org/details/experimentalimmuOOmark

TABLE OF CONTENTS

P age

Acknowledgement
Dedication
Introduction

i
ii
1

Historical Background
A,

Endogenous pyrogen

1

B,

Mononuclear cells as pyrogen producing
cells

5

C,

Mononuclear cell interactions with
antigen-antibody complexes

10

D,

Experimental immune fever

17

Materials and Methods

33

Results

44

Conclusions and Discussion

52

Summary

69

Bibliogranhv

70

.

ACKNOWLEDGEMENTS

I would like to acknowledge the help given to me by
the following individuals.

The success of this research

is in large part theirs.
Dr,

Phyllis Bodel, an energetic and inspiring physician,

researcher and teacher.

She surely is more capable than

most of providing a stimulating educational experience in
medical research.
Dr.

Elisha Atkins,

for his valuable criticisms, suggest¬

ions and his contagious fascination with all natural phenomena.
Dr,

Frances Pitlick,

for her constant interest, help

and her invaluable thoughts on cellular and macromolecular
function,
Dr,

Frank Richards and Dr.

Robert Rosenstein,

for their

aid in understanding antibody structure and function.
Dr.

Richard Donabedian for his invaluable aid and

advice in utilizing radioactive tracer techniques.
Mrs.

Lorraine Francis,

for her constant willingness to

help and to teach, and most of all for her constant cheer¬
fulness, brightening even the darkest of days,
Mrs,

Jean Bruiter,

for her'helpful technical assistance.

1

DEDICATION

Dedicated to Prentiss, Patricia and Karen Markle for
unfailing love and support in all things.

11

INTRODUCTION
Fever is one of the commonest manifestations of
immunity and hypersensitivity.

Although many aspects of

hypersensitivity reactions have been exhaustively studied,
the mechanisms by which immune processes produce fever,
and the relationship of fever to immune phenomena have been
the subject of only few investigations.

This research

project was undertaken to investigate the possibility that
pyrogen production by mononuclear blood cells could result
from interaction of cells with antigen-antibody complexes.
Mononuclear cells from peripheral blood of human volunteers
were chosen for this study,

since methods are available

for isolation of these cells, and the monocyte is known
to be a pyrogen-producing cell

(1),

In addition, monocytes

are the probable precursors of most tissue macrophages,
cells which are known to interact with antibody and antigenantibody complexes, both in. vivo and in. vitro, and which
may plav an important role in immune fever.

No previous

in vitro studies have demonstrated pyrogen release from
cells in response to antigen-antibody complexes.
HISTORICAL BACKGROUND
Endogenous Pyrogen
Fever as a manifestation of disease has been well
known for centuries, yet it is only in recent decades that
the pathogenesis of this response has in part been elucidated.
Although most commonly associated with diseases of infectious
origin,

it is also a manifestation of man*' diverse processes

■
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associated with inflammatory states including neoplasia,
hypersensitivity reactions,

infarction and mechanical injury.

Dickensen (2) recognized in 1785 that fever seemed to be
brought about by the absorption of the products of the
injured cells of a febrile animal.

However,

the demonstra¬

tion that fever is actually caused by factors derived from
host cells was first accomplished when differentiation of
"endogenous” or cell pyrogens could clearly be made from
the endotoxins of gram negative bacteria.
In 1948,

Beeson

(3)

showed that cells, predominantly

polymorphonuclear leukocytes,

obtained from sterile, saline

induced, peritoneal exudates, were capable of producing
fever when injected into a normal rabbit.

He showed, more¬

over, that a soluble fraction of such cells obtained by
mechanical lysis was the responsible factor;

cell debris

was not pyrogenic.

(4)

Earlier work by Billroth

19th century and by Fenkin

(5)

in the

in 1943 had suggested that

cells from purulent exudates released a soluble pyrogen,
but these ^reparations were very likely contaminated with
bacterial endotoxin, so the observed febrile responses
were of indeterminate etiology

(6).

However, using tech¬

niques to avoid endotoxin contamination,

Bennett and Beeson

(6) surveved extracts of normal rabbit tissues for
pyrogenicity and found that only peritoneal exudate cells
and cells from Arthus and Schwartzman lesions were caoable
of oroducinp febrile responses when injected into normal
animals.

This leukocyte oyrogen was shown to produce
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fevers with a latent period of 10 to 15 minutes, and a
peak response within one hour.
labile and nondialyzable

(7),

The substance was heat
Subsequent work has shown

that the endogenous pyrogen molecule contains essential
peptide bonds, has a molecular weight of 10,000 to 20,000
and requires free SH groups for activity (8,9,10),

Of

great significance were the findings that febrile tolerance
did not appear after repeated injections and that there was
no cross tolerance in animals which were tolerant to the
effects of bacterial pyrogens

(11).

The first evidence that

such an endogenously produced mediator was present in the
circulation of febrile animals and that it could clearly
be distinguished from the bacterial pyrogen producing the
fever was presented by .Atkins and Wood

(12),

They showed

that, after injection of typhoid vaccine into rabbits, two
different pyrogenic substances could be demonstrated in
their serum.

A pyrogen which was present in the serum

gathered 5 minutes after typhoid injection, was inactive
when injected into rabbits previously rendered tolerant
to the vaccine.

A pyrogen present in serum drawn at 2

hours, however, when the animal was febrile, was active
in both normal and tolerant animals.

The early appearing

pyrogen produced responses similar to those induced by
bacterial pyrogens;

the responses of the late appearing

pyrogen was similar in character to that of leukocyte
pyrogen.

Furthermore, when tolerance to the typhoid vaccine

in the recipient animals was reversed,

febrile responsive-

■
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ness to the exogenous pyrogen returned and could be
correlated with the reappearance of endogenous pyrogen in
the serum of the challenged animal.

So it appeared that

exogenous bacterial pyrogens produced fever indirectly by
liberating from the cells of the host an

'endogenous

pyrogen’ which effected changes in the thermoregulation of
the host.

Endogenous pyrogen was further differentiated

from gram negative endotoxins on the basis of its full
effects on animals rendered granulocytopenic and therefore
relatively unresponsive to bacterial pyrogen infections

(13),

The endogenous pyrogen also was shown to have a potentiated
effect when infused into the carotid artery, whereas intra¬
venous or intra-carotid infusion of bacterial pyrogen
produced equivalent responses.

Work by Cooper (14) had

shown that integrated thermoregulatory changes were
mediated by the action of endogenous pyrogen in the
anterior hypothalamus; the carotid infusion of endogenous
pyrogen therefore presented very high concentrations at its
site of action.
Endogenous pyrogen release from stimulated cells has
been shown to be associated with the fever due to numerous
other infectious agents.

Gram positive bacteria appear to

stimulate cells by a variety of mechanisms ,
cellular actions of liberated toxins,

including

phagocytosis of

bacterial particles, and immune reactions.

A variety of

virus-induced fevers are associated with endogenous ovrogen
release

(15,16).

Culture filtrates of various pathogenic

.

‘
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fungi

(17), and a protein extract of cryptococci

(18) appear

to cause fever by inducing endogenous pyrogen production
by host leukocytes, probably as a result of immune processes.
Certain non-microbial substances have been shown to be
pyrogenic.

For example, some prostaglandins cause fever

when applied directly to the hypothalamus

(19); perhaps

they function normally as intermediates in responses
mediated by endogenous pyrogen.

Steroids such as etio-

cholanolone primarily act by inducing endogenous pyrogen
release from cells

(20),

Endogenous pyrogen from cells of different species
are variously pyrogenic in other species.

While rabbit

endogenous oyrogen is inactive in dogs, guinea pig and
mouse cell pyrogens are active in rabbits

(21).

Of great

experimental usefulness is the activity of human endogenous
pyrogen in rabbits since this orovides an easy and reliable
assay of human pyrogen (22).
Mononuclear Cells as Parogen Producing Cells
In early work by Bennett and Beeson
and Wood

(6,7)

and by King

(23), endogenous pyrogen was obtained from sterile

exudates composed mainly of granulocytes.
shown by Snell and Atkins

(24)

However,

it was

that small amounts of substance

with activity indistinguishable from, that of granulocyte
endogenous pyrogen could be extracted from homogenized,
uninfected rabbit tissues such as muscle,
soleen,

liver and kidney.

lung, heart,

Neither endotoxin nor sequestered

polymorphonuclear leukocytes could account ror the pyrogen

.

■
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thus extracted.
The first direct evidence that nononuclear cells could
be a source of endogenous pyrogen production come from the
work of Bodel et al_ (25).

First,

it was shown that blood

from patients with agranulocytosis was capable of producing
endogenous pyrogen when stimulated with heat killed
Staphylococcus albus.

Such blood ^reparations had 4 percent

or less neutrophils by differential count.

Incubation with

staphylococci of numbers of polymorphonuclear leukocytes
comparable to those in these blood preparations produced
only minimal amounts of pyrogen.

Similarly, blood from

patients with monocytic and myelomonocvtic leukemia was
capable of producing endogenous pyrogen when incubated with
staphylococci.

The numbers of contaminating granulocvtes

were inadequate to account for the amount of pyrogen
produced.

Also, normal blood monocytes, isolated by their

low densitv, through albumin density centrifugation, and
by their propertv of sticking to glass surfaces, according
to the observations of Bennett and Cohn

(25), were found to

produce endogenous pvrogen in response to phagocytosis of
staphylococci.

Again, contaminating granulocytes could not

account for the observed activity.
Hahn et al

(27) showed that peritoneal macroohanes

harvested from oil induced exudates in rabbits also could
be a source of endogenous pyrogen.

Pvrogen production by

these cells could be distinguished from that of granulocytes
by the macrophages'

capacity to produce endogenous pvrogen

7

for periods of time significantly longer than was nossible
for granulocytes•under the same incubation conditions.
Further direct evidence linking monocytes and monocyte
derived tissue macrophages was gathered by Atkins,
and Francis

(28)

Bodel

using tissues from rabbits previously

sensitized to BCG (Bacillus Calmette-Guerin).

Blood and

lung macroohages when incubated with Old Tuberculin (O.T.)
released amounts of pyrogen in proportion to the dose of
O.T,

present in the incubation mixture whereas spleen and

lymph node preparations were entirely inactive.

It was

shown that more lung macrophages were required to produce
an amount of pyrogen equal to that produced by a given
number of blood leukocytes.

They showed further that the

lung macrophages were capable of continued endogenous
pyrogen release even after the stimulus had been removed.
These cells released little or nofpyrogen after five hours
incubation, minimal amounts after eighteen hours,

and greater

amounts in a supportive medium (buffer plus glucose)

than

in just saline, a requirement not shown for granulocytes.
However, it was observed that,

like granulocytes the lung

cells required incubation at 37°C and their pyrogen produc¬
tion was inhibited by blocking protein synthesis with
puromvcin.

That different activators may react with different

tissues ^as demonstrated by the finding that spleen and
lymph node preparations, while not responding to O.T., were
capable of pyrogen release when stimulated bv phagocytosis
of heat-killed staohvlococcus.

In all of these studies it

■
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was shown that the numbers of contaminating granulocytes
were inadequate to account for the observed pyrogen release.
Work by Dinarello et al (29)

showed that a preparation

of liver cells was active in pyrogen production in response
to stimulation by O.T., heat killed staph and endotoxin.
A separation of these cells into fractions of Kupfer cells
and hepatocvtes and subsequent stimulation showed that the
Kupfer cells were uniformly responsible for the observed
activity.
Human peripheral blood monocytes isolated according
to the methods of Boyum (30)

and incubated in tissue

culture, have been shown to release pyrogen in response to
endotoxin to heat killed staph and to tuberculin
unpublished observations).

(Bodel,

This preparation of mononuclear

cells represents a cell population remarkably free of
contaminating polymorphonuclear leukocytes

(less than 1%)

and rendered moderately free of lymphocytes by allowing
the monos to fix to the plastic surface of the tissue
culture flask and then decanting the remaining medium con¬
taining the lvmphocvtes. .

This is the monocyte system used

in the experiments reported below.

In no svsten has the

lymphocyte, when free of other known pyrogen producing
cells, been observed to release any pyrogenic substance

(31).

Moreover, the monocyte is a much more potent source of
endogenous oyrogen than is the granulocvte.

Unlike the

lower potency of lung macrophages, oeripheral monocvtes
have been shown to produce several fold greater amounts

.
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of pyrogen per given number of cells than do polymorpho¬
nuclear leukocytes when stimulated by etiocholanolone
or when stimulated by phagocytosis of heat killed
staphylococci

(32).

And, to date, no discernible differences

had been noted in the pyrogenic response curve from a
single injection nor in the shape of the dose response
curve for monocytes as compared to polymorphonuclear
leukocytes.
It must be noted that monocytes placed in tissue
culture undergo profound morphological and metabolic
changes, transforming into macrophage-like cells, epithelioid
cells and multinucleate giant cells

(33,34,35).

However,

the time required for isolation of these cells and fixation
to the tissue culture flasks is approximately 6 hours and
while some transformation has been observed in such cells
over such a time period, they are minimal.

They include

an increase in cytoplasmic pseudopodia, an increase in smooth
endoplasmic reticulum, more numerous lysosomes, and the
appearance of cvtoolasmic filaments

(35).

However,

all of

these changes are minimal, especially compared with the
marked morphological changes occurring at times of 24 hours
or more.

Similarly, the most marked metabolic changes of

the cells characteristically occur after 24 or 43 hours

(34).

So the pyrogen producing mononuclear cells in the oresent
experiments are probably more

like the peripheral blood

monocyte than a well differentiated tissue macrophage.

10

Interactions between Mononuclear Cells and An 11 p e n - An 11 b o d v
Complexes
The first direct evidence that cells interact specificall
with antibodv in such a way as to mediate the uptake of
foreign antigen by mononuclear cells came from the work of
Boyden and Sorkin
tion.

(36)

using a rabbit spleen cell prepara¬

When these cells were treated with specific anti¬

sera to human serum albumin and then washed, they were
capable of specifically adsorbing the antigen.

Boyden (37)

later demonstrated that peritoneal macrophages were the
active receptor cells in such reactions, unlike oolvmorphonuclear leukocytes or lymphocytes.

Also he demonstrated

that the reaction could occur with large
antigens such as red blood cells.

‘particulate’

When serum from guinea

pigs immunized with sheep red blood cells was mixed with
guinea pig peritoneal macrophages, and sheep red cells were
added, the red cells were specifically adsorbed and formed
"rosettes" about the macrophages.
That the interaction is specifically mediated by
antibody is clear, since without soecificallv immune serum
present there is no rosette

formation

negligible uptake of smaller antigens

(36), and there is
(38,39).

Berken

(40)

showed that rosette formation with peritoneal macrophages
occurred to a greater extent with cells
than from immune animals.

from non-immune

And LoBuglio ewt al

(41) noted

sphering of D positive red cells, sensitized with anti-D
antibodies, about leukocytes from either D positive or D
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negative donors.

Furthermore, Huber (42) had shov/n that

red cells coated non-immunologically with immunoglobulins
would form rosettes, and Arend and Mannik

(39)

showed that

heat aggregated immunoglobulin could be bound to macro¬
phages.

So the reaction is apparently mediated by anti¬

bodies .
Berkin
to E.

(40)

demonstrated such a "cytophilic antibody"

coli polysaccharide.

Huber et al

(43)

found similar

results using isolated peripheral monocytes, hepatic
macrophages, and a splenic macrophage preparation.

However,

he too observed that lymphocytes were not capable of such
activity, even when stimulated with a variety of phyto¬
mitogens,
lets
cytes

However,

subsequent data indicates that plate¬

(44), polymorphonuclear leukocytes

(44), and B lymoho-

(45) have receptors for components of antigen-antibody

complexes or complexes of antigen, antibody, and complement.
Specific antibodv-mediated uptake of antigen by macrophages
has been studied in several systems.
radish peroxidase

Antigens include horse¬

(38), heterologous protein antigens such

as human serum albumin

(39), and small polyvalent haptens

(46).
Only certain classes of immunoglobulins appear to
function in mediating uptake.
’cytophilic’

Berkin et al

(40) noted that

antibody for macrophages appeared at approxi-

matelv the eighth day of immunization and further noted
that it had a 7S sedimentation coefficient.

He also noted

that the active antibodies migrated along with other slow
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migrating,

complement fixing antibodies.

Rabinovitch (47)

shotted that globulins with a high sedimentation coefficient
were inactive, unlike 7S fractions.

In addition, treatment

of the 7S antibodies with pepsin markedly diminished their
binding properties.
by Berkin et al

Similar results had been shown previously

(40).

This finding irrralicates the Fc region

of the antibody in the attachment reaction.

Huber et a!L

(42) showed that for peripheral blood mononuclear cells,
IgM antibody failed to induce rosette formation, whereas
IgG antibody was effective.

Using purified myeloma anti¬

bodies of specific subclass, he showed that IgG-|_, and IgGg
were most effective, while IgG2 and IgG-4 were

least active.

He showed further that pepsin digestion of the antibody
partially reduced its activity, whereas papain digestion
eliminated all binding activity.
confirmed by Abramson et al_ (48)

These findings were
and LoBuglio et al

(41).

In several models, both rosette formation and uptake
of soluble antigens was easily inhibited by free antibody
Dresent in the reaction medium,

in amounts equal to or less

than those found normally in the plasma.

For this reason,

the relevance of the interactions observed in vitro between
cells and antigen-antibody comnlexas to in. vivo events is
not clear.

However,

other mechanisms seemed to play a role

in producing the observed ohenomena.

Huber et al

(42)

orooosed that interaction between cells and comolexes
proceeded in two stems,

first binding and then ohagocytosis.

Thev noted, as had Berkin et al

(40)

that In order to
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observe rosette formation, the reaction had to be carried
out at room temoerature.
phagocvtosed.

At 37°C the red cells were readily

And it became apparent that both binding and

phagocytosis were in some way intimately tied to activity
of the complement system.
The role of complement in the attachment of Comdexes
to cells has received much attention.

Berkin et al

(40)

noted that rosette formation was not altered when the serum
had been heated to 56°C, and Huber et al

(42) showed that

the reaction occurred in the absence of complement.
in another series of experiments,

However,

using red cells coated

with antibody alone or with antibody and complement, these
authors observed that while binding and ingestion could
occur in the absence of complement, the inhibitory effects
of free IgG on binding were not observed when complement
was present.

They found that C3 was the active comdement

component in this reaction, since cells coated only with
Ci,

C^_4 or C]_42 were not bound in the presence of free

IgG, and addition of Cgg7 also did not enhance the inter¬
action.

Since free IgG did not inhibit binding if added

after red cell attachment had taken dace,

it was concluded

that the function of complement was to enhance the attach¬
ment, not the ingestion step.

The authors further concluded

that there was a separate complement "recentor" on the
monocyte.
such a role

Work by Mantovani et al

(49)

further confirmed

for comdement, showing, at least at low con-

■
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centrations of red cell bound IgG, that the effect of
was

greater on the attachment phase than on the ingestion

phase*

They also noted that by adding anti-IgG to a system

with no complement,

ingestion of antibody coated erythrocytes

was reduced more than attachment.
role for the complement

They concluded that the

’receptor’ was primarily for

attachment and that the role for the IgG receptor was
primarily for ingestion.

However, Abramson et al

(48),

using cells coated with antibodies, and coated with C3
but then washed free of antibody, observed that neither
binding nor phagocytosis took place.

Thus, no direct

evidence for the existence of a separate,
plement

’receotor’ was demonstrated.

functional com¬

Furthermore, incomplete

removal of antibodies from such complement coated cells
resulted in some reosette formation.

Nonetheless,

comole-

ment appears to enhance interactions of antibodv-coated
particles and cells.

It may act by altering the cell

surface through its enzymatic activity

(50,51), since

pretreatment of monocvtes with various proteolvtic enzvm.es
has been demonstrated to enhance both rosette formation
(52)

and uotake of soluble complexes

(39).

The importance of complement is not so clear, however,
in experiments where adherence of soluble immune complexes
has been studied.

Arend and Mannik

(75)

noted that uotake

of soluble, circulating complexes of HSA and rabbit antiHSA by the liver occurred at the same rata in normal and
in complement-depleted animals.

In addition,

complement
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did not reverse the inhibiting effect of free IgG on the
macrophage-antigen-antibody complex interactions in vitro.
IgG in buffer inhibited the interaction as well as did IgG
in serum.

Complement-depleted serum containing free IgG

inhibited adherence just as well as did serum containing
complement.

The authors postulate that the role of comple¬

ment in mediating interactions between mononuclear cells
and soluble antigen-antibody complexes may be to potentiate
phagocytosis, not adherence, perhaps by means of its peptidase
activity.

A number of factors have been shown to govern

the uptake of non-particulate antigen-antibody complexes
by mononuclear cells.

The size and structural complexity of

the•complexes, the total numbers of antibody-receptor
interactions, and allosteric effects on the rc region
induced by the antibody’s interaction with antigen all may
have a role in determining the extent of binding of
complexes to cells.
Multiple antibody-receptor interactions are necessary
for effective cellular uptake of soluble complexes.
Quagliata et al

(46),

in studies using monovalent,

Phillipsdivalent,

and polyvalent small haptens, measured the amount of binding
of antibodv to macrophages, and the effects of each kind of
antigen on that binding.

They found that there was a great

increase in binding of antibody to cells when the antibody
and cells were reacted in the presence of polyvalent antigen
in amounts comparable to an equivalence precipitation,
There was a smaller increase in bound antibodv when divalent

■
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antigen was added, and there was no increase when mono¬
valent antigen was present over a wide range of antigen
concentrations.

Furthermore,

large excesses of mono- or

divalent hasten blocked the uptake of antibody mediated by
polyvalent antigen.

They noted that binding was optimal in

slight antibody excess with the polyvalent antigen.
extreme antigen excess,

In

even with the polyvalent antigen,

there was no uptake of antibody by the cells over the
baseline level.

Noting that free IgG almost completely

inhibited binding, meaning that it already has an exposed
site for binding with the receptor, the authors propose
that it is primarily a summation of numerous antibodyrecestor bindings which accounts for the specific attachment
of structurallv complex antigen-antibody complexes, not
allosteric effects of antigen on the antibody mediating
a tighter binding between the receptor and the antibody’s
Fc region,
Arend and Mannik

(39), however, by comparing the

greater binding of soluble antigen-antibody complexes with
that of aggregated IgG,

concluded that efficiency of

binding was not solely mediated by summation of individual
binding sites.

However, they also showed that large complexe

of greater than IIS sedimentation coefficient selectively
adhered to the nacroohases.

Soluble complexes of IIS or less

did not adhere as well, and these smaller complexes were
determined to be a molecule of antigen with one or two
molecules o^ antibody.

The complexes which bound best were,
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therefore, complexes containing at least one antigen molecule
and at least two antibodies.

This would seem to support Phillip-

Quagliata's data showing that summation of binding sites
interactions does play a role, but also shows that conforma¬
tional changes in the Fc region mediated by interaction with
antigen may play a role in formation of a firm attachment
between antibody and monocyte receptor, especially since
large protein antigens produce greater conformational changes
than small molecules

(53).

So it seems apparent then that

interactions between antigen-antibody complexes and cells
is not a simple one and may be a multiphase process which
depends on various factors or combinations of factors such
as cell type, size and structure of antigen,
antigen-antibody ratio of immune complexes,

size and
complement

mediated mechanisms, total number of interactions between
antibody and receptor, and allosteric effects due to the
antigen-antibody interaction itself.
Experimental Immune Fever
It has been suspected since early in this century that
mechanisms of hypersensitivity could be responsible for fevers.
The fever associated with known

’toxic'

effects of microbes

and their products, notably the endotoxin of Pram negative
bacteria, were well known.

However,

it was postulated early

in this century that the fever of certain infectious diseases
might in fact be due to mechanisms of hypersensitivity

(54).

In 1964, Farr was first able to produce fevers using
non-bacterial heterologous protein antigens injected into
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specifically sensitized animals

(55).

He found after giving

rabbits injections of 10 mg of bovine serum albumin

(BSA)

three times a week for 3 to 6 weeks, that approximately 70
oercent of such animals would respond with fever when given a
2 mg injection of the BSA.

Numerous other antigens have

proven to be pyrogenic when injected, including human serum
albumin (HSA)

(56), bovine gamma globulin

culture filtrates of staphylococcus
protein extract of cryptococcus
drugs such as Penicillin
(61).

(60),

(3GG)

(57), and

(58), certain fungi, a

(18), Old Tuberculin

(59),

and numerous other drugs

Febrile reactivity to some substances appears to be

due to immediate humoral hypersensitivity, e.g.
and HSA (56)

and Penicillin

BSA (55)

(60), while others appear

to be related to "delayed" hypersensitivity, e.g.

staph

(58); fever to tuberculin may be the result of a mixed
response to a variety of antigen substances in the tuberculin
preparation

(62),

That immune fever could be produced in states of
"delayed"

tyoe hypersensitivity had been clearly demonstrated

when IJhr (63) and coworkers observed febrile responses in
guinea pigs which had been sensitized with antigen-antibody
complexes in antibody excess such that no circulating antibod
was oresent, but in which the typical skin reactivity of
delaved hypersensitivity was oresent.

In the orocess of

"desensitizing" such animals with a single large dose of
antigen, Uhr observed that desoite the loss of local skin
reactivity after the infection,

there was a systemic resoonse

N

mR
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which included fever, lymphopenia and a later secondary
antibody response

(64).

It is of some minor interest that an alternative to
an endogenous pyrogen mediated pathway, in the febrile response
associated with delayed hypersensitivity states was proposed
by Johanovsky (65).

He claimed to be able to obtain by

incubation of antigens such as tuberculin with mononuclear
cells and cell extracts of hypersensitive animals the release
of a pyrogen with response characteristics unlike that of
endogenous pyrogen.

It was a substance which could act with

no latent period, which could, unlike endogenous pyrogen,
be produced at 4°C and could be produced in the absence of
intact cells.

Work at Atkins and Heijn

(66), however,

did

not corroborate these findings; rather it was shown that BCG
(Bacillus Calmette-Guerin)-sensitized cells incubated in the
presence of tuberculin released endogenous pyrogen.
addition, normal, i.e.

In

non-sensitized, blood cells incubated

in the plasma from sensitized animals would also release endo¬
genous pyrogen when stimulated by tuberculin in vitro.

This

implies that the fevers produced by tuberculin mav well have
had an antigen-antibody mediated component, since mixtures
of tuberculin with sensitized rabbit plasma in_ vitro did
produce fever

when injected into normal animals, and had

the characteristic delayed response of other immune fevers.
is more recent evidence for fever production mechanisms
unrelated to the formation of antigen-antibody complexes
delayed hypersensitivity.

In an effort to study fever in

m

There
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"pure” delayed hypersensitivity, Atkins et al sensitized
rabbits to various heterologous proteins and protein hapten
conjugates and studied pyrogen production in vitro by
various tissues in the presence of the conjugate and carrier.
This was done at a time when negligible amounts of precipi¬
tating antibody were present.

The results indicated that

interaction of antigen with sensitized lymphocytes released
a soluble substance, possibly a

’lymphokine’, which stimulated

pyrogen-producing cells to release endogenous pyrogen

(57).

In Farr’s original results with BSA injections in
sensitized animals, febrile reactivity to injected antigen
seemed to be correlated with the presence of detectable
antibody, in that precipitating antibody was present in all
animals responding with fever, and no animal without detectable
antibody responded to injection with fever.

However, the

exact role of specific antibody was unclear since there were
animals which had the antibody present in their serum but
in whom no febrile response developed to the injected
antigen

(55).

Grey et a!L
due to injection

(6 7)

provided the first evidence that fever
non-bacterial protein antigens was

primarily a phenomenon of "immediate,” or ’’humoral"
hypersensitivity, by successfully inducing febrile reactivity
in normal animals by passive transfer of specifically-immune
serum to non-immune recipients.

rive of seven recipients

thus sensitized responded with fevers of 1°F or more when
challenged with the BSA antigen.

Passive transfer of non-
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hyperimmune serum produced no such reactivity in "the recipient,
and there was no response in normal, non-immune animals
given only 3SA, thereby demonstrating the non-pyrogenicity of
the BSA itself.

However, spleen cell suspensions transferred

to normal animals conferred no reactivity on the recipient
when challenged.

The results clearly implicated humoral,

not cell-mediated, mechanisms.
The work of Mott and Wolff (56)

continued to mount

evidence for the significance of antigen-antibody interactions
when they showed a rough correlation between the degree of
temperature change and the antibody titer of specificallysensitized animals challenged with an injection of antigen,
in this case human serum albumin

(HSA),

They also noted that

of the six rabbits which had been sensitized (according to
the protocol used for all the animals), but in whom challenge
with HSA elicited no febrile response, all six had undetectable
antibody.

Furthermore,

febrile reactivity to injected

antigen in normal animals passively sensitized with speci¬
fically immune serum was

comparable in incidence to that

seen in immune animals.

However,

of seven normal animals

passively "sensitized” with the "immune" serum containing
no demonstrable antibody,

only one responded Tn.th fever to

challenge.
Some clinical evidence to implicate the role of antigenantibody interactions in the pathogenesis of fever was
presented by Brittingham and Chaplin

(68) who noted that

febrile reactions to blood transfusions were associated with
demonstrable antibodies against donor leukocytes in the
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serum of those patients who had had both numerous

(20 to 55)

transfusions and repeated transfusion reactions.

This group

of patients responded with fever when injected with buffycoat preparations of donor blood units, whereas the remaining
red cell suspension of the donor blood resulted in no such
response.

This was compared to the responses of patients

who had had fewer transfusions and no history of transfusion
reaction.

This group did not respond with fever to injection

of either buffy coat or red cell suspension.

Immuneiinter¬

actions were shown to be related to the fevers of certain clini¬
cal hemolytic disorders by Jandl and Tomlinson, who showed that
hemolytic episodes due to immune hemolysis led to fever
whereas hemolysis due to non-immune mechanisms had no such
associated fever (69).

Moreover, the degree of fever seemed

to have no correlation to the degree of hemoglobinemia
produced by different immune mechanisms, so fever correlated
only with the presence of immune interactions, not with
hemolvsis oer se.
The work of Root and Wolff (70) was the first to directlv
implicate antigen-antibody complexes as the specific pyrogenic
mediator.

They showed that antigen-antibody complexes ore-

pared i_n vitro were regularly pyrogenic when injected into
normal animals, a finding confirmed by Mickenberp et al_ (71).
The pattern of febrile resoonse was used as an imoortant
differentiating characteristic in separating out the action
of endogenous ovrogen from the less direct effects o^ the
antigen or the antipen-antibodv comolexes.

Unlike the

■
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response to endogenous pyrogen, which has been shown to be
a prompt, monophasic fever with a latent period of approxi¬
mately 10 to 15 minutes

(7), the fever curve after injection

of antigen into sensitized animals was prolonged, with a
longer latent period, a greater time interval to the oeak
of the response, and a greater total duration

(72).

These

same response characteristics were observed by Mott and Wolff
after injection by HSA (56), by Grey in passive transfer
experiments, and by both Root and Wolff (70) and Mickenberg
et al_ (71)

in normal animals injected with antigen-antibody

complexes.
The Dhenomenon of febrile tolerance proved to be a
helpful tool to differentiate the pyrogenic effects of
injected antigen from the effects of endogenous pyrogen
to which tolerance has not been observed.

Farr

(72)

noted

originally that if sensitized rabbits which responded with
fever to challenge with antigen were given repeated doses
of the antigen,

the febrile responses to the repeated injections

became progressively smaller, with complete tolerance being
achieved after 3 or 4 such injections.

Several lines of

evidence suggest that the phenomenon of tolerance to com¬
plexes differs from that of endotoxin tolerance, and may
not be due simply to more rapid clearance from the circulation.
Mott and Wolff

(56)

showed that the response to antigen in

a sensitized animal was unaffected by a concomitant state
of endotoxin tolerance in the animal, and that febrile toler¬
ance to antigen could not be abolished with reticuloendothelial

.
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blockade with Thorotrast,

Furthermore, tolerance to antigen

could not be passively transferred to sensitized animals,
in clear distinction with endotoxin tolerance.

Root and

Wolff (70) also showed that the febrile response of normal
animals to antigen-antibody complexes also was unaffected
by a state of endotoxin tolerance.

And Mickenberg et al

(71)

showed that tolerance to antigen-antibody complexes could
persist when concomitant endotoxin tolerance in the same
animal

was reversed by reticuloendothelial system blockade

with thorium dioxide.

Thus,

the pyrogenic effects of antigen

in specifically-sensitized animals and of complexes in
normal animals,

can be readily differentiated from the direct

effects of endogenous pyrogen and from the effects of con¬
taminating endotoxin.
Root and Wolff, utilizing these phenomena, postulated
a mechanism for the febrile reactivity to antigen injected
into specifically sensitized animals.

By challenging

specifically sensitized rabbits with HSA and then collecting
serum at 5 minutes after challenge and at 2 hours after
challenge, thev identified two pyrogenic substances in this
serum by injecting these collections into normal, unchallenged
animals.

The late-appearing pyrogen, present in the serum of

febrile donors at 2 hours post-challenge, had characteristics
identical to that of endogenous pyrogen, and the serum from
afebrile doners 2 hours post-challenge had no pyrogenic
acitvity.

However, the serum from donors

(all of whom were

afebrile) at 5 minutes post-challenge gave pyrogenic response
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characteristics unlike that of endogenous pyrogen and more
like that observed in sensitized animals challenged directly
with antigen.

They demonstrated that at any time in the

first hour after injection of antigen into a sensitized
animal, approximately 50 oercent of the HSA was globulin
bound, thereby suggesting that the HSA was present as
circulating antigen-antibody complexes.

It was the ability

to produce febrile tolerance to injected antigen in a
sensitized animal which enabled Root and Wolff to infer
that their early appearing pyrogen was in +fact antigenantibody complex, and that the mechanism by which it pro¬
duced fever was by release of endogenous pyrogen by the
cells of the animal.

By rendering

complex tolerant-

the rabbits which were given the early and late pooled
serum collections, it was then observed that the late
appearing pyrogen was able to mediate its effects in spite
of complex tolerance.

But the response of the early

pyrogen in such complex tolerant animals was abolished.

It

was inferred that the early appearing pyrogen in the serum
of sensitized animals challenged'with antigen, which had a
fever curve indistinguishable from that of antigenantibody complexes, and which had no effect in animals
previously rendered Comdex tolerant, was,
antibodv complex.

in fact,

antipen-

And it was clear that the late appearing

nyrogen, which had a fever response curve identical to that
of endogenous pyrogen,

and which was active desoite Comdex

tolerance, was indeed endogenous pyrogen.

So it was postu¬

lated that the mechanism wherebv protein .antigen such as HSA

.
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produced fever in actively or passively immune animals is by
interaction with specific antibody to form antigen-antibody
complexes which then interact with the cells of the host to
stimulate the production and release of endogenous pyrogen.
Grey et al

(67) had postulated earlier that immune fever

was probably mediated not directly by antigen or by
complexes, but by a series of reactions in vivo since thev
noted the long lag phase of the immune fever curve and noted as
well that the time required for antigen-antibody inter¬
actions could not account for that time delay.
In fever mediated bv antigen-antibody complexes, it
is now apparent that only certain classes of antibody are
probably involved (56), that the structural characteristics
of the complex play a role

(73), and that interactions with

other immune mechanisms, namely the complement system, nav
play a role

(73).

There is evidence that precipitating antibodies mediate
the pyrogenic response to antigen-antibody Comdexes.
in his original observations

Farr

(55) noted that specific kinds

of antibodies might be involved, although he

(incorrectly)

concluded that precipitating antibody was not the active
factor in serum, because of the observation that some
animals with demonstrable precipitating antibodies to 3SA
did not respond to the challenge of antigen.
and Wolff (70)

However, Foot

showed with complexes prepared i_n vitro that

soluble complexes

in antigen excess, prepared by solubilizing,

with antigen, the washed precipitates

formed at equivalence,

■
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were as active in producing fever as were the soluble
complexes prepared simply by adding antigen directly to
the immune serum.

Furthermore, the supernatants from

the equivalence precipitation reactions were uniformly ncnpyrogenic when injected.

This evidence seems to clearly

implicate the precipitating antibodies as the active partici¬
pant in the febrile response to antigen-antibody Comdexes.
That specific immunoglobulin classes may be responsible
for febrile reactivity can be inferred from the results of
Jandl and Tomlinson

(69)

in their work on the fever of

immune hemolytic eoisodes.

It was observed that hemolysis

due to "incomplete” anti-D antibodies oroduced significantly
more fever than did hemolysis due to A-anti A or 3-anti 3
interactions.
the IgG

The "incomplete" anti-D antibodies are from

(Immunoglobulin G)

class whereas anti A and anti 3

antibodies are IgM molecules

(41).

The significance of this

class difference in relation to Jandl and Tomlinson’s
findings is significant in light of the evidence gathered
by Mott and Wolff (56)

that passive transfer of febrile

reactivity to injected HFA was successful only with fractions
of serum which were shown by immunoelectroohoresis to con¬
tain predominantly 79

globulin.

That fraction which was

rich in 19S macroglobulin produced no significant febrile
reactivity in the oassively

’sensitized'

host.

Thus,

it

seems that soecific characteristics of different immuno¬
globulin classes may have importance in determining the role
of any immunoglobulin in the pathogenesis of immune fever.

.
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The macromolecular composition of immune complexes may
play a significant role in producing fever.

It is clear

that in any given reaction mixture of antigen and antibody,
whether in vitro (74)

or in vivo (75), there is a hetero¬

logous mixture of different molecular species covering a broad
range of molecular antibody to antigen ratios, including
both free antibody and free antigen.

And since these

different molecular species seem to be handled by the host
in different ways

(75), and since they have different in

vitro biological as well as physico-chemical characteristics
(76), it is not surprising then that febrile reactivity to
"antigen-antibody complexes" may represent the effects of
one

(or more) particular range or type of molecular species,
It was well documented by Arend and Mannik (76)

that

complexes of different macromolecular characteristics
differ in their clearance from the circulation.

They demon¬

strated as well that a given reaction mixture of antigen
with antibody contains a bread range of macromolecular
species, of varying antibody to antigen molecular ratios.
By subjecting complexes of HSA-anti HSA orepared in 5 times
antigen excess to a density gradient centrifugation they
observed a variety of resultant peaks:

a 6.6S peak repre¬

senting unbound antibody and comprising approximately 20
percent of the total; and a broad spectrum of larger complexes
from 14S to 22S which comprised approximately 46 percent of
the total.

Then by sequential timed sampling of the serum

of a rabbit after injection of soluble complexes prepared

'
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at five and at twenty tines antigen excess, and ultracentri¬
fugation of these sanples, it was shown that there was a
three phase exponential disappearance curve.

There was a

rapid initial exponential component represented by uptake
of the large

(greater than 11S)

complexes.

Other work

showed that 99 percent of this uptake occurred in the liver
(75),

There was a second exponential phase representing

rapid equilibration of the 11S complexes,

followed by a

third prolonged exponential phase corresponding to slow
catabolism of the IIS and 6.6S components.
the large

(>11S)

Furthermore,

complexes were most active in their in

vitro comdement fixing activity, since approximately ten
times as many of the 11S complexes were required to fix an
equivalent amount of complement.

However, comolement

depletion of animals prior to injection of complexes had no
effect on

the rapid uptake of the large

(

IIS)

Comdexes.

So it is clear that the in vitro activities of different
species of complexes may not necessarily be of significance
in determining their in vivo activities as it relates to
clearance.

And the authors concluded that the characteris¬

tics of the complexes which permit raoid clearance from the
circulation parallel those which relate to comolement fixa¬
tion, but that the two characteristics are not necessarilv
functionally related i_n vivo.
Documentation that macromolecular composition of com¬
plexes may play a role in fever pathogenesis came when Root
and Wolff

(70)

first produced fever in rabbits using HSA-

.
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anti-HSA complexes prepared rn vitro.

They observed that com¬

plexes prepared at 10 times antipen excess

(i.e. by adding, to

serum 10 times the amount of antigen required for equivalence)
produced significant fevers consistently/.

Complexes pre-

Dared at 21 times antigen excess or at 3 times antibody excess
produced lower and more variable responses.

Mickenberg (73),

however, showed that the structural characteristics of com¬
plexes may determine the degree of the fever response
indirectly,

through variable ability to fix complement.

They showed that rabbits could be made febrile either by
%

injection of PISA into an immunized animal or by injection
of 10 times antigen excess complexes into a normal animal.
However, treatment of these animals with cobra venom factor
(resulting in complement depletion)

orior to injection would

abolish the responses of normal animals given the soluble
complexes, whereas sensitized animals given antigen retained
febrile reactivity.

Since it was suspected that injection

of antigen into a sensitized animal resulted in formation
of large complexes like those formed at near equivalence or
in antibody excess

(75),

complexes were preoared in 3 times

antibodv excess, and when injected into unsensitized animals,
were pyrogenic even in cobra venom treated animals.

further¬

more, animals could be made tolerant to 10 times antigen
excess complexes by repeated injections of the complexes.
(This treatment also produced partial comolement depletion).
However, such "complex tolerant" animals would still resoond
with fever when injected with the antibodv excess complexes.

31

So it was apparent that a role for complement in the
febrile response to soluble conolexes prepared in 10 times
antigen excess was possible.

Also, complement depletion

seemed to affect other host responses to injection of Com¬
dexes:

there was a decrease in the thrombocytopenia, a

decrease in the duration of the leukopenia, and a marked
reduction in the complement consumption observed as part
of the response.

Complement was further implicated by

absence of an explanation of complex tolerance on the basis
of more raoid clearance from the circulation or on the
basis of a derangement of the effects of leukocyte endogen¬
ous pyrogen on the thermoregulatory center.

That is, the

only demonstrable change in complex tolerant animals was a
(partial)

dedetion of complement.

On the other hand,

it

was not clear that complement played any role in the
response to the antibody excess complexes, since complement
depletion by previous treatment with cobra venom factor
did not alter the response,

and since the response was not

altered even in those animals which were tolerant to the
soluble 20 times antigen excess complexes.

This set of

observations was especially interesting in light of the
fact that the antibody excess Comdexes fixed comdement
in vitro much more rapidly than did the soluble antigen
excess complexes and there was no significant difference in
their in v: vo comdement consumotion.

However, the difference

in the in vivo consumotion mav well be related to markedly
more raoid clearance of the larger complexes,

thereby de-
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creasing the total exposure time to serum complement compon¬
ents .
So it seems clear that different ill vivo and in vitro
biological as well as phvsiochemical properties may play a
complexly inter-related role in the mechanism or mechanisms
of immune fever.

And it seems obvious that some of these

complexities might be sorted out by determining how the
complexes interact with the cells of the host when some of
these parameters such as duration of presence in the circu¬
lation, complement requirements, and macromolecular compo%

sition of the complexes could be controlled; that is, a
studv of the narameters governing the interaction of com¬
plexes with host cells in vitro
ever,

would seem helpful.

How¬

such studies have not been forthcoming and numerous

attempts to stimulate cells in vitro with antigen-antibody
complexes have been unsuccessful, using blood cells,
Kunffer cells, hepatocytes, and mononuclear cells from
spleen preparations

(31),

However, it seemed reasonable to

attempt to stimulate monocytes in tissue culture, as the
monocyte reoresents the probable cellular orecursor of many
tissue macrophages

(34),

and this preparation had been shown

to be active with other stimuli such as heat-killed staphy¬
lococcus albus and endotoxin
tions).

Additionallv,

(.Bodel, unpublished observa¬

the preparation is relatively sure

in that one can eliminate most of the polymorphonuclear
leukocytes and most o^ the small lymphocytes
contaminating cell type).

(the chief
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MATERIALS AND METHODS
Care of Materials and Anirials
All glassware and instruments were rendered pyrogen
free, after washing, by being heated in a dry oven at 170°C
for at least 2 hours.

Solutions and reagents were auto¬

claved at 120°C and 20 pounds pressure for at least 30
minutes.
New Zealand albino female rabbits,
were used as test animals.

6 kg in weight,

Temperatures were continuously

recorded by a rectal thermistor probe connected to a con¬
tinuous graph readout.

The ambient temperature of the

recording room was maintained at 68 to 72°F.

Animals

were restrained in stalls during temperature recording,
and had been trained by at least two 3-hour periods in
such stalls prior to assay injections.
Method of Injection and Recording of Temperatures
The rabbits'

temperatures were allowed to equilibrate

such that a steady baseline temperature recording of at
least one hour's duration was obtained.

Each animal was

given an initial injection of normal saline prior to assay
injections.

All were given into a marginal ear vein.

Since

animals may be somewhat refractory to the effects of endo¬
genous pyrogen during the hours following one profound
febrile episode

(77),

injections into animals directly

after high or prolonged fever was avoided.

After a moderate

febrile response, when the temperature had returned to its
baseline value, at least one hour elapsed before the next

-
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injection was given.

Only those responses which were of

rapid onset, monophasic type were considered as true endo¬
genous ovrogen mediated responses

(7),

Maximum temperature

change from baseline was used as the measure of febrile
response.

Occasionally, high fevers would be preceded by

a slight, brief drop in temperature;

in these instances,

the maximum temperature rise was measured from the original
baseline.

In almost all experiments, pyrogenic testing

of control and experimental samples was performed in the
same group of rabbits, so that effects

of variable

responsiveness of individual rabbits on experimental results
were minimized.

Each rabbit received only 6 to 7 consecu¬

tive days of injections of human material, to prevent the
complication of hypersensitivity fever

(55).

Immunization of Rabbits and Collection of Hyperimmune Serum
Commercially prepared Bovine Gamma Globulin
(Armour Pharmaceutical Co,, Chicago,

(BGG)

IL) was dissolved in

0.1 Molar phosphate buffer, pH 7.0 to a concentration of
5 mg per ml.

Eight ml of this solution was mixed with an

eaual volume of complete Freund’s adjuvant, and 0.5 ml
portions were injected into each footpad of 4 New7 Zealand
albino rabbits.

Booster injections of 1 mg of BGG were

given intravenously four weeks later.
later,

Seven to ten days

the animals were sedated with sodium barbital and

bled by cardiac puncture.

Some animals received another

1 mg of BGG intravenously 2 weeks after the first intra¬
venous injection, and were bled subsequently.

Samples of
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all sera were cultured to confirm the absence of contamina¬
tion, and were tested for specific antibody activity against
BGG by Ouchterlony precipitation techniques.

All sera

were then pooled, divided into 5 ml aliquots, and frozen at
-20°C,

For the purposes of quantitative precipitation and

formation of complexes for cell stimulation, 1:4 and 1:2
dilutions were made in 0.1 Molar phosphate buffer, pH 7.4
Iodination of BGG
A solution of BGG was labeled with a radioactive tracer
for the purpose of determining the equivalence point of the
pooled sera by quantitative precipitation technique.
Conjugation with protein with 1^25 was accomplished accord¬
ing to the methods of Greenwood et al

(78).

To 10 micro¬

liters of a 5 mg/ml solution of BGG was added 3 mCi of 1^25
neutralized in 0.1 Normal HC1, and 20 microliters of
Chloramine T (1.7 mg/ml in water) was added.

This mixture

was allowed to stand for 60 seconds and then the reaction
was stopped by addition of 50 microliters of Sodium meta¬
bisulfite.

This reaction mixture was then filtered through

a Sephadex G-100 column equilibrate with 0.1 M phosphate
buffer and successive 1 ml samples were collected.

Aliquots

of each tube were diluted and counted on a Nuclear Chicago
scintillation counter,

The first peak of radioactivity was

saved, representing labeled protein rather than conjugated

.
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Quantitative Precipitation of BGG with Rabbit Antiserum
In order to determine the zone of equivalence for the
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pooled sera, a quantitative precipitation was carried out.
An initial precipitation was first performed by adding 1.0
ml of 1:4 dilution of rabbit antiserum to varying amounts of
a 1.0 mg/ml solution of BGG,

These reaction mixtures were

incubated at 37°C for approximately 10 minutes and then
centrifuged at room temperature at 500
an IEC Model PR-2 centrifuge.

g for 20 minutes in

The supernates were decanted,

and the precipitates washed with 0.1 Molar phosphate buffer,
pH 7.4,

followed by recentrifugation for a total of three

such washings.

Then the precipitates were solubilized in
a

0.5 ml of a 0.5 Normal solution of acetic acid, and made
up to 20 ml by addition of water.

Total protein concen¬

tration of these solutions were estimated by determination
of O.D,

at 280 millimicrons using a Coleman Model III

spectrophotometer.

These initial results Indicated an

approximate range of antigen concentration for the zone of
equivalence to be around 0,6 mg BGG Der 1 ml of 1:4 dilution
of the rabbit antiserum.
A further precipitation test was then set up using BGG
conjugated with 1-^5 as a tracer.
1 mg/ml solution of BGG

(.4 ml to

To variable amounts of a
.8 ml) was added 20 micro¬

liters of the solution of radioiodinated BGG.

This mixture

was well agitated on a Vortex .mixer, and 1.0 ml of a 1:4
dilution of the pooled rabbit antiserum was added to each
tube.

These were quickly mixed on the Vortex mixer,

incubated at 37°C for 30 minutes and then centrifuged at 500
for 20 minutes.

Supernatants were drawn off with a Dasteur

g
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pipette and saved.

Each pellet of precipitate was then

gently resuspended in 5 ml of 0.1 M phosphate buffer, pH 7.4,
and centrifugation repeated.

This supernatant was drawn off

with a Pasteur oipette and added to the original supernatant.
This washing orocedure was repeated twice more.

Finally the

washed pellet of precipitated complexes was solubilized in
0.5 ml of a 0.5 Normal acetic acid solution and diluted to
a total of 20 ml with water; supernatants were also made
up to a final volume of 20 ml.
A 1 ml aliquot of both supernatant and resolubilized
precipitate was then counted for 1 minute in a Nuclear Chicago
scintillation counter.

The O.D.

of the resolubilized pre¬

cipitates was then determined in a Coleman III spectro¬
photometer at 280 millimicrons to determine the total pro¬
tein content of the precipitate.

The assumption was made

that an O.D.

reading of 1,5 units represented 1,0 mg/ml

of protein.

The amount of antibody precipitated in each

tube was then calculated by subtracting the amount of antigen
in the precioitate, determined by the radioactivity of the
solubilized precipitate,

from the total orotein content of

the precipitate as determined by the O.D.

reading.

Assump¬

tions were made that the small amounts of radioiodinated
3GG were negligible in relation to the amount of unlabeled
antigen, and that labeled and unlabeled 3GG were well mixed
and behaved identically; in the process of combining with
the antibody.

The equivalence point was chosen as that dose

of antigen which precipitated the maximum amount of antibody.
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Preparation of Complexes
Soluble immune complexes in 10 times antigen excess were
prepared in. vitro by adding 10 times the amount of antigen
required for equivalence to a given amount of a 1:2 dilution
of antiserum in a small test tube.

The mixture was immediately

agitated on a Vortex mixer and then incubated for approxi¬
mately 1/2 hour at 37°C,

The mixtures were then centrifuged

at room temperature, at 1000

g for 20 minutes.

The super¬

natants were then decanted and added directly to tissue
culture flasks containing the prepared monocytes.

Complexes

in 10 times antibody excess were similarly prepared by
adding 10 times the amount of antibody required for equiva¬
lence to a given amount of antigen.

Similarly prepared

complexes were formed at 50 times antigen excess.

The dose

of complexes given to cells was varied by changing the
concentration of BGG and the dilution of rabbit antiserum
used in forming the precipitates.

This method of varying

the dose of complexes was chosen in order to maintain a
constant volume of stimulus added to the tissue culture
flasks, thereby eliminating the possible effects of differ¬
ential dilution of the culture medium by different stimuli.
In cases where flasks were to receive no stimulus or a
colume of stimulus material less than 1.0 ml in volume,

the

additional volume was added in the form of 0.1 Molar phos¬
phate buffer, pH 7,4.
Precipitated complexes at equivalence and at 3 times
antibody excess were prepared by adding the appropriate
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amounts of antigen and antibody,

incubating and centrifuging

the mixture as above, and then decanting the supernate.
The pellet was then gently resuspended in phosphate buffer
(.1 Molar at pH 7.4) and recentrifuged at 1000 g for 10
minutes.

This washing was repeated twice, the final super¬

natant decanted, and the pellet was resuspended in an amount
of phosphate buffer equal to the total initial reacting
volume, with agitation on a Vortex mixer.

Samples of this

suspension of antigen-antibody complex particles were added
directly to the tissue culture flasks of the monocytes.
Isolation of Peripheral Monocytes
Human peripheral blood monocytes and lymphocytes were
isolated according to the method of Boyum (30).

All

procedures were performed with sterile, pyrogen free glass¬
ware and solutions, and utilizing sterile technique
throughout.
Twenty ml of 50% Hypaaue

(sodium diatrizoate),

of a 9% aqueous solution of Ficoll

(a large polysaccharide

polymer, molecular weight approximately 400,000,
Pharmacia Fine Chemicals, Upsala,

70.6 ml

from

Sweden), and 9.4 ml of

water were combined and 8 ml aliquots of this Hypaque-Ficoll
solution were placed in 40 ml conical glass centrifuge
tubes,
Peripheral venous blood from healthy human volunteers
was drawn directly from venipuncture into a large heparinized
syringe

(10 units/ml heparin).

An additional 30 ml of

unheparinized blood was drawn fro serum,

Approximately 120 m

\
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of blood was mixed in a large flask with approximately
260 ml of saline and stirred slowly with a magnetic mixer while
32 ml aliquots were gently layered over each 8 ml aliquot
of the Hypaque-Ficoll solution.

These tubes were then cen¬

trifuged at room temperature, at 400 g,

for 40 minutes.

After centrifugation red cells and PMNs were found at the
bottom of the tubes.

Approximately 1 to 2 cm above the

upper border of this button was a white ring containing
monocytes and lymphocytes.
30 ml of clear solution.

Above this ring was approximately
This top layer of solution was

removed by suctioning gently through a Pasteur pipette;
the layer of monocytes and lymphocytes was then carefully
removed with a 5 ml pipette with a pipette bulb attached.
It proved helpful to scrape the sides of the glass with the
tip of the pipette to remove attached cells.
from two such centrifuge tubes

The rings

(approximately 10-12 cc)

were combined in a new 40 cc conical centrifuge and diluted
with 30 cc of a solution of Krebs-Ringer Phosphate buffer
(KRP) containing 10 units/ml of heparin.

After thorough

mixing with a 10 ml pipette the tubes were centrifuged at
room temperature, at 150 g,

for 15 minutes, the wash super¬

natant discarded by suctioning, and the cells gently resus¬
pended in 0.5 to 1 ml of tissue culture medium (Minimal
Eagles Medium with 50 units per ml of penicillin and
streptomycin, and 200 millimolar L-nlutamine),

All the

cells were collected to make a pool or approximately. 8 ml
of cells in tissue culture medium,

A white blood cell

.
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count was performed on a Coulter cell counter Model
(Coulter Electronics, Hialeah,

FL),

A small drop of the

cell suspension was placed on a coverslip with a drop of
albumin and smears were made for differential cell count.
A total of 120 ml of peripheral blood usually yielded 15
7
to 20 X 10

cells of which 20 to 35% were monocytes,

remainder being lymphocytes.

the

Granulocytes accounted for

0 to 1% of the cells thus isolated.

In some experiments,

numbers of monocytes were confirmed by incubation of 0.2 ml
of the cell suspension at 27°C for two hours with a drop
of a suspension of heat killed staphylococci
particles per ml).

(3 X 10^

These cells were then suspended in 30

ml of normal saline, centrifuged at room temperature, at
400 g, for 15 minutes,- The supernate was decanted and the
cell pellet suspended in a drop of albumin; coverslip smears
made prepared,
under oil.

stained with Wright’s stain and examined

Cells containing staphylococci were counted.

Numbers of phagocytic cells compared well with estimates
of monocyte count made by morphology.
Incubation of Cells
Tissue culture flasks were prepared containing approxi¬
mately 2 X 10^ cells

(approximately 4 to 6 X 10^ monocytes)

in a total volume of 6 ml,MEM with 15% homologous serum.
Flasks were then gassed with 5% CO2 -in air, blown through a
sterile,

cotton plugged Pasteur pipette, and incubated at

37°C for 3 hours.

At this time, when the monocytes were

observed to have attached to the bottom of the flask, the

-
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medium and floating cells

(i.e.

lymphocytes) were removed.

Four ml of fresh medium, with 20% serum, was then gently added
to the flasks,
solutions.

followed by 1 ml of experimental or control

The final concentration of serum in the flask

remained 15%.

The flasks were then again gassed with 5%

CO2 in air and incubated overnight
5% CO^ incubator.

(16 to 18 hours)

in a

After examination of the cells under a

20X tissue culture microscope, the supernatants from the
flasks were then transferred to centrifuge tubes, centri¬
fuged at 1000 or 2000

g.

The higher speed was used for

supernatants containing staphylococcal particles.
supernatants were then drawn up into svringes;

The

two to

three drops of each supernatant was added to tubes of
thioglycolate broth and cultures incubated for at least
3 davs to assure sterility.

Data from injection of anv

material which proved to be contaminated was excluded from
the final results.
In each experiment in which cells were obtained from
a single donor,

supernatants from all experimental flasks,

usually six to nine, were tested for pyrogen in the same
rabbits.

Usually supernatant from a single flask provided

two test injections which were given to two different
animals.
Analysis of Data
In order to convert results of pyrogen assays to numbers
with linear scale parameters, maximum temperature changes
( & T max) were converted to units of pvrogen dose.

The

'
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rationale and techniques of this procedure is as follows.
When increasing doses of a preparation of human monocyte
pyrogen were injected into a group of rabbits, a laganthmic
function was observed.
0,9°C,

A

(Fig.

1)

In the range of 0.3°C to

T max increases almost proportionally with dose,

but a plateau is reached after which only small increases
in

& T max can be observed in response to relatively

increases in the amount of pyrogen injected.

large

Similar

response characteristics have been observed previously for
human and rabbit granulocyte pyrogen
observations).

(77,

Bodel, unpublished

When the monocyte pyrogen response curve is

plotted as a function of the logarithm of the dose of pyrogen
administered, and the results analyzed by statistical tests
for trend
curve.

(79), a linear function best describes the

The best line describing the curve was determined

by the method of least squares.
analyzed, individual

When experimental data was

AT max values were converted to pyrogen

dose units bv use of this curve,

A single pyrogen dose unit

was defined as the amount of pyrogen required to effect a
A T max of 0.3°C, a minimal positive febrile response.

The

range of pyrogen units extended from 1.0 to approximately
8.0 units.

The scale of pyrogen doses was set to comply

with this definition of a minimal febrile response, and all
^ T max values were then converted to some constant
multiple of the minimal pyrogenic dose unit.
any response of

Therefore

/A T max equal to 0,3 C or greater corresponds

to a pyrogen dose of 1.0 or greater, and is interpreted to

FIGURE 1
DOSE RESPONSE CURVE FOR
HUMAN MONOCYTE PYROGEN
AVERAGE VALUES WITH
RANGES OF RESPONSES
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be a significant amount of pyrogen.

Any

A T max of less

than 0.3°C corresponds to a pyrogen dose of less than 1,0
and probably represents an insignificant amount of pyrogen.
Any response which was not included within the range of the
dose response curve was excluded as being uninterpretable.
In the figures below, the data is presented as the statis¬
tical mean of at least 14 individual values, reported with
confidence limits determined by the two-tailed t test

(30),

The number of actual observations made is also included.
RESULTS
Preparation of 1^25 Iodinated BGG
In preparation for a quantitative precipitation test
iodination of BGG with 1^25 was performed.

After column

chromatography of the reaction mixture in a Sephadex G-100
column, two peaks of radioactivity were obtained, as shown
in Fig.

2.

As shown by others, the first peak includes

the iodinated protein, and the broader second peak repre¬
sents unconiugated radioactive iodine

(78),

Determination of the Equivalence Point
A series of quantitative precipitations were performed
in order to determine the relative amounts of pooled antiserum
and BGG required for equivalence,

A preliminary precipitation

using only non-iodinated BGG showed that maximum precipitation
occurred when 1 ml of a 1:4 dilution of the pooled antiserum
was reacted with approximately
mg/ml solution).

.6 mg of BGG

(0.6 ml of a 1

In order to further define the range of

equivalence, precipitations were done using BGG to which 20

,

FIGURE 2.
E1^ IODINATION OF BOVINE GAMMA GLOBULIN.
ACTIVITY OF THE CHROMATOGRAPHED ANTIGEN.
;0UNTS PER MINUTE x 104 OF ELUATE FRACTIONS

10

9

8

7

6

5

4

3

2

1

ELUATE - TUBE #

45

of I125 iodinated BGG had been added.

The relative amounts

of antigen and antibody in the supernatant and in the pre¬
cipitate were determined as described in Methods.

Equivalence

was defined as the point at which the maximum amount of
antibody was precipitated.

In Fig.

3, the milligrams of

antibody precipitated is plotted against the amounts of
antigen added to each reaction mixture,

Maximum antibody

was precipitated when 0,55 mg of BGG was reacted with 1,0
ml of a 1:4 dilution of the rabbit antiserum.

This deter¬

mination was then used to calculate amounts of antigen and
antibody needed to form complexes of varying ratios in
antigen or antibody excess.
Additional quantitative precipitations were done with
reaction mixtures containing 10 times antigen excess and 10
times antibody excess to examine the total amount and compo¬
sition of protein in the soluble complexes present in the
supernates of such mixtures.

This was done to determine

whether marked differences in total dose of soluble complexes
would result from the two reaction mixtures.
minted that,

It was deter-

in a 10 times antibody excess mixture, approxi¬

mately 64% of the antigen remained in the supernatant:

and

in a 10 times antigen excess mixture, approximately 71% of
the antibody remained in the supernatant.

These findings

indicated that supernatants of these reaction mixtures con¬
tained

roughlv similar amounts of protein, although it is

likely that the exact molecular species present would differ
markedly

(74),

FIGURE

3

QUANTITATIVE PRECIPITATION.
EQUIVALENCE RANGE OF RABBIT
ANTISERUM & 1125 LABELED BGG
MILLIGRAMS OF ANTIBODY
PRECIPITATED BY ANTIGEN

MG.

OF ANTIGEN ADDED
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Temperature Responses of Rabbits to Human Monocyte Pyrogen
Monocytes were incubated in tissue culture flasks over¬
night with heat killed staphylococci, and the supernatant
was injected into rabbits.
is shown in Fig,

4.

A typical temperature recording

The characteristics of this febrile

response resembles those previously reported for leukocyte
endogenous pyrogen, both human and rabbit

(1,

25).

There

was a latent period after injection of approximately 15
minutes, followed by a monophasic rise in temperature peaking
within or at one hour and returning to the baseline within
1 to 2 hours.

Rabbits with higher peak temperature responses

usually required more time to return to their normal base¬
line.

No differences in the shape of the curve were

apparent when other kinds of stimuli were used to initiate
pyrogen production by these cells.
Pyrogen Production bv Monocytes Incubated with Soluble Com¬
plexes in Antigen Excess
Monocytes were incubated in the presence of soluble
antigen-antibody complexes formed in 10 times antigen excess.
Control flasks included one with monocytes incubated in
medium without antigen or antibody,

one with monocytes

and antiserum, and one with monocytes and antigen.

In

addition, a flask containing heat killed staphylococci was
included to provide a positive control.
one such experiment are shown in Fig.

5.

The results of
Each curve repre¬

sents the average temperature response to 2 or more test
animals.

Whereas control injections produced little or no

fever, injection of supernatants from cells plus soluble

.

FIGURE 4

RABBIT TEMPERATURE RESPONSE TO
MONOCYTE ENDOGENOUS PYROGEN

TEMPERATURES REPRESENT THE AVERAGE
VALUrS OF TWO RA.33IT RESPONSES TO INJECTION
_J' OF THE PRODUCT OF APPROXIMATELY
2 X 106 MONOCYTES

FIGURE 4.
RABBIT TEMPERATURE RESPONSE TO
MONOCYTE ENDOGENOUS PYROGEN.
0-0 UNSTIMULATED MONOCYTES
□ » □ MONO*S & STAPHYLOCOCCI

TIME AFTER INJECTION

(MIN.)

,

FIGURE 5

RABBIT FEVER RESPONSE TO MONOCYTE
PYROGEN PRODUCED IN RESPONSE TO
ANTIGEN-ANTIBODY C 0M? LE XE S

TEMPERATURES REPRESENT THE AVERAGE
VALUES OF TWO RABBIT RESPONSES TO INJECTION
OF THE PRODUCT OF APPROXIMATELY
2 X 106 MONOCYTES

FIGURE 5
RABBIT FEVER RESPONSE
TO MONOCYTE PYROGEN.
STIMULATION OF MONO’S
BY SOLUBLE COMPLEXES IN
10 TIMES ANTIGEN EXCESS.
0-0 MONOCYTES ALONE
A—A MONOCYTES WITH BGG.
OR WITH ANTISERUM.
□ —□ MONOCYTES WITH IMMUNE
COMPLEXES.
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complexes produced clear, reliable febrile responses.
A summary of the data from 14 experiments of this kind
is presented in Fig.

6.

As shown in bar A, monocytes incu¬

bated without any added material produced insignificant amounts
of pyrogen.

Since a minimal positive pyrogenic response

(AT max of 0.3°C)

corresponds to a Dyrogen dose unit of

1,0, the mean value for monocytes alone, is 0.6
(p <. 0,001, n=24).

-

.12 units

That is, there is less than a 0,1%

chance that monocytes alone produce significant amounts of
endogenous pyrogen.
Similarly as shown in bar B, monocytes do not produce
significant amounts of pyrogen after addition of either 3GG
or antiserum, in doses equal to or greater than those
present in the preparations with soluble complexes.
mean value for these pyrogen doses

The

(taken together to

provide a statistically adequate number of trials), is
0.72

~

.06 units

(p < 0.001, n=14).

That is, there is less

than a 0.1% chance that cells in the oresence of BGG or
rabbit antiserum produce significant amounts of pyrogen.
3y contrast as shown in bar D, addition of soluble
complexes to monocytes stimulates the production of endo¬
genous oyrogen.

The value of the mean pyrogenic dose for

these supernatants is 2.3 i

,88 units

significantly greater than 1,0,

(p <. .001, n=36),

Heat killed staohylococci

were also potent stimuli of oyrogen production by monocytes
(see bar E),

The mean pyrogenic dose was 3.3 i

(p -c 0.05, n=17).

.79 units

This corresponds to a mean temperature

FIGURE 6

MONOCYTE PYROGEN PRODUCTION BY DIFFERENT
CELL STIMULI (IN PYROGEN DOSE UNITS)
1 UNIT PYROGEN 3= 0.3°C A T MAX

A.

MONOCYTES ALONE - CONTROL

B.

MONOCYTES WITH BGG ALONE OR WITH
ANTISERUM ALONE - CONTROL

C.

ANTIGEN-ANTIBODY COMPLEXES ALONE,
WITHOUT CELLS - CONTROL

D.

ANTIGEN-ANTIBODY COMPLEXES IN 10
TIMES ANTIGEN EXCESS (HIGH DOSE)
WITH MONOCYTES

E.

MONOCYTES WITH HEAT-KILLED STAPHY¬
LOCOCCI

BARS REPRESENT STATISTICAL MEANS WITH 99%
CONFIDENCE LIMITS, AND REPRESENT THE
PRODUCT OF APPROXIMATELY 2 X 10b MONOCYTES

r1GURE b
MONOCYTE PYROGEN PRODUCTION
BY DIFFERENT CELL STIMULI.
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response somewhere in the range of 0,67 to 0,84°C,
In order to demonstrate that the pyrogen present in
supernatants from tissue culture flasks containing cells and
complexes was, in fact, endogenous pyrogen, and not
antigen-antibody complexes themselves, the following
experiment was performed.

Tissue culture flasks without

cells were prepared containing tissue culture medium and
soluble complexes.

These flasks were incubated and treated

identically to other flasks which contained cells.

Injections

of the centrifuged supernatants were uniformly non-pyrogenic,
the mean pyrogen dose being 0,4
n=15)

(see Fig.

6, bar C).

-

.14 units

(p < 0.001,

Thus the pyrogen present in

flask supernates after incubation of complexes with
monocytes was most likely due to a substance produced by
the cells in tissue culture rather than the complexes alone.
Pyrogen Production bv Monocvtes Incubated with Varying
boses of Soluble Anti pen-Antlbody Complexes m To Times
Anti pen Excess
To test whether the amount of pyrogen produced by the
monocytes was directly related to the number of complexes
added, equivalent numbers of cells in culture were stimulated
with different amounts of soluble complexes prepared in 10
times antigen excess.

Equal volumes were maintained by

diluting the solutions of antigen and antibody before
preparing the complexes.

The lower dose was

given by adding

1 ml of soluble complexes prepared by mixing a 1 mg/ml
solution of 3GG with a 1:4 dilution, in buffer, of the
rabbit antiserum, or by adding 0.5 ml of :uffer plus 0.5 ml
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of the high dose solution.

The high dose solution was

given by adding 1 ml of soluble complexes prepared by mixing
a 2 mg/ml solution of BGG with a 1:2 dilution of the rabbit
serum.

As seen in Fig,

7, bars

BSC, there is a positive

correlation between the concentration of complexes added to
the monocytes and the amount of pyrogen produced.
dose of complexes stimulated production of 1.5
of pyrogen

(p

There is

.18 units

0.01, n=23), while the higher dose of com¬

plexes stimulated production of 2,3
n=36).

-

The low

-

,67 units

(p <0,01,

less than a 1% chance that the two doses

stimulate production of equivalent amounts of pyrogen.
Comparison of Production of Monocyte Pvro?en in Fesnonse
to Qualitatively Different Antigen-Antibody Complexes'
Since complexes of varying size and differing antibody
to antigen ratio are known to have different in vivo and in
vitro biological activities, the effects of soluble com¬
plexes prepared in 10 times antibody excess and in 50 times
antigen excess were compared to those of the 10 times
antigen excess complexes.
Fig.

8,

The results are presented in

Soluble complexes in 10. times antibody excess

stimulated production of 1.9
n=18).

-

.90 pyrogen units

(p < 0.01,

This finding indicates that soluble complexes in

antibody excess are also capable of stimulating cells.
Although this figure is

lower than the one for 10 times

antigen excess, direct comparison of the 10 times antibody
excess complexes with the 10 times antigen excess complexes
seems not justified, since differences in pyrogen production
follow alteration in dose of complexes

(see above), and it

■V

*

V

FIGURE
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DOSE RELATIONSHIP OF PYROGEN PRODUCTION TO
CONCENTRATION OF ANTIGEN EXCESS COMPLEXES
(IN PYROGEN DOSE UNITS)
1 UNIT PYROGEN = 0.3°C
T MAX

A.

MONOCYTES ALONE - CONTROL

3.

MONOCYTES WITH HIGH DOSE COMPLEXES

C.

MONOCYTES WITH LOW DOSE COMPLEXES
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FIGURE ?
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FIGURE 8

MONOCYTE PYROGEN PRODUCTION IN
RESPONSE TO IMMUNE COMPLEXES OF DIFFERENT
ANTIBODY: ANTIGEN RATIOS.
SOLUBLE AND PRECIPITATED COMPLEXES

A.

10 TIMES ANTIGEN EXCESS

B.

10 TIMES ANTIBODY EXCESS

C.

50 TIMES ANTIGEN EXCESS

D.

COMPLEX DREClPITATES

BARS REPRESENT STATISTICAL MEANS WITH 95%
CONFIDENCE LIMITS, AND REPRESENT THE PRODUCT
OF APPROXIMATELY 2 X 10° MONOCYTES

FIGURE 8
MONOCYTE PYROGEN PRODUCTION IN
RESPONSE TO IMMUNE COMPLEXES OF
DIFFERENT ANTIEODY:ANTIGEN RATIOS.
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was not possible to accurately quantitate numbers of complexes
in each system.

However,

it was noted that a mixture of

10 times antibody excess complexes produced a significantly
larger pellet of precipitate than did the 10 times antigen
excess complexes.

Thus, the amount of complexes present in

soluble form was probably less than that in the 10 times
antigen excess mixture.
Complexes prepared in 50 times antigen excess were also
added to the monocytes, and pyrogenicity of the supernatants
determined.

In this case, the amount of complex present

in the soluble form was clearly greater than that found in
the 10 times antigen excess mixture.

However, stimulation

of pyrogen production by the soluble complexes prepared at
50 times antigen excess was not clearly demonstrated; the
mean pyrogen dose was 0.8 Fig.

8, bar C.

.17 units

(p ^.0.4, n-14),

This indicates that there is an approxi¬

mately 80% probability that the mean amount of pyrogen
produced was not a significant amount.

The response was

clearly lower than the response to 10 times antigen excess
complexes, even though there were at least as many soluble
complexes present at 50 times antigen excess, since there was
virtuallv no precipitate in this mixture.
Response of Monocytes to Anti gen-Ant ibodv Comp lex

ne c

tates~
Since monocvtes produce pyrogen after simple phagocy¬
tosis of particles such as heat killed ssaphvlococci , it
was necessary to be sure that the responses

observed with

soluble complexes were not due to phagocytosis of particles

'

»
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of precipitated complexes which might remain after centri¬
fugation or which might form inadvertently in the flasks.
In addition, the effect of precipitates of antigen-antibody
complexes on monocyte pyrogen production was of interest.
Therefore, precipitates formed at equivalence, at 3 times
antibody excess, and at 10 times antibody excess were
prepared, washed 3 times to remove any remaining soluble
complexes, resuspended in phosphate buffer, and added to
the standard cultures of monocytes.

The results of these

supernatant injections are shown in Fig.

8, bar D.

Immune

precipitates uniformly failed to induce pyrogen production.
The mean pyrogen dose was 0.6

-

,08 units

(p < 0,001, n=19).

In order to ensure that the precipitates had not injured
the cells, preventing them from producing pyrogen, an
experiment was included in which heat killed staphylococci
with and without precipitates were added to some cells.
In this case, a large amount of pyrogen was produced, both
in the presence and absence of precipitates, in response
to the staphylococci.

Thus there was no evidence that the

precipitates inhibited pyrogen production.
Microscopic Observations of Monocytes in Tissue Culture
Tissue culture flasks were usually examined,after
incubation for approximately 18 hours, under a tissue
culture microscope at 20X magnification.
may be summarized as follows.

The observations

Monocytes incubated in medium

alone appeared as cells which were fixed to the flask
surface, with minimal numbers of cells floating free in the
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medium;

cells were separate and unclumped, round or oval,

and displayed a minimal granular appearance to the cyto¬
plasm with occasional ameboid shapes with cytoplasmic extensions.
Cells that had been stimulated by either staphylococci or
antigen-antibody complexes in 10 times antigen or antibody
excess appeared somei'Niat larger, most still fixed to the
surface, but often with significant numbers of floating,
single cells or cell clumps.

Cells fixed were often

clumped together and were usually round.

A more heavily

granular appearing cytoplasm was evident in most cells,
fixed and floating.

In general, these changes of clumping

and granularity were produced to a greater degree by
stimuli in the following order:
soluble,

staphylococci

> high dose

10 times antigen excess complexes > soluble 10

times antibody excess complexes > low dose soluble 10 times
antigen excess complexes.

In general, soluble,

50 times

antigen excess complexes produced only minimal changes.
Negligible changes were observed with BCG alone or with
antiserum alone.

However, resuspended precioitates were

found to produce marked changes as described above, with
large masses of floating cell clumps as well as some fixed
cell clumps.

Because more accurate microscopy was not per¬

formed the exact relationship of these changes to specific
alterations in cell morphology is not known,
CONCLUSIONS AND DISCUSSION
The results of these experiments indicate that immune
complexes can interact with pyrogen producing cells to
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stimulate the production of endogenous pyrogen.
and Wolff

While Root

(73) have shown previously that injection of anti¬

gen into a sensitized animal was associated with the appearance
of endogenous pyrogen in the circulation, the in_ vivo
pathways, presumably involving interactions of complexes
with some cells, were unknown,

Atkins et al attempted to

stimulate blood cells, predominantly polymorphonuclear
leukocytes, with complexes of rabbit antiserum and BGG-DNP,
and failed to generate any detectable pyrogen

(57).

However,

only complexes in 30 to 1 and 80 to 1 antigen excess were
used as stimuli, and these complexes have been shown in the
present experiments to be relatively ineffective in
stimulating monocyte pyrogen production.
vitro model,

Chusid and Atkins

(60)

In another in

incubated leukocytes

from rabbits hypersensitive to penicillin-protein conjugates
with antigen and antiserum and noted endogenous pyrogen
production.

However, since the blood preparation was

undoubtedly a mixture of PMNs and monocytes, the specific
pyrogen-producing cell in this system is not known.

In the

present experiments it is extremely unlikely that contamina¬
ting numbers of PMNs are responsible for the observed
responses.

Less than 1% PMNs were counted in the differ¬

ential smears of the cell preparations;

therefore, no

more than 2 X 10^ PMNs were present in any flask.

Atkins-

and Bodel (1) reported that any number of PMNs below 5 X
g
10
produced negligible amounts of pyrogen in response to
tuberculin.

Contaminating granulocytes,

therefore,

could
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not account for the pyrogen production by incubated monocyte
preparations.

Lymphocytes are also probably not responsible

for pyrogen production in these experiments, since cultures
of the non-adherent cells

from monocyte-lymphocyte prepara¬

tions with added complexes did not result in endogenous
pyrogen production

(Bodel, unpublished observations).

other systems tested,
pyrogen

(31).

In all

lymphocytes have failed to produce

Lymphocytes present in tissue culture flasks

may play a role in the observed endogenous pyrogen produc¬
tion,

Some lymphocytes were doubtless present, even after

non-adherent cells were removed, since the monolayers were
not washed in any way.

And lymphocytes have well-described

receptors for antigen-antibody complexes
numerous effects on macrophages

(83),

(45), and exert

It is possible,

therefore, that the complexes may act on the lymphocytes,
which in turn stimulate the monocytes to release pyrogen.
The observed febrile responses to suoernatants from
cultures of monocytes plus complexes were clearly due to
pyrogen produced in the incubated cells.

Complexes incu¬

bated without cells in tissue culture medium did not produce
significant fevers when injected into test animals in
amounts equal to or greater than those present in flasks
containing both cells and complexes.

Thus, the complexes

themselves in those small concentrations were non-pyrogenic
in rabbits.

Further evidence for this conclusion that

the comnlexes were not acting directly on the cells of
the test animal is found in the shame of the fever curve

-
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which looks indistinguishable from a tyoical endogenous
pyrogen mediated response.
The results also demonstrated that, in the case of
soluble complexes formed at 10 times antigen excess, the amount
of pyrogen released by the cells was directly related to the
concentration of complexes added to the cells.

This could

indicate that a single cell produces more pyrogen when it
experiences more interactions with complexes.

On the other

hand, a minimum number of cell interactions with complexes
may be required to stimulate any cell to respond with
pyrogen production.

When the number of complexes present

in the medium is increased, more cells may achieve inter¬
actions with the minimum numbers of complexes.

It is not

known whether stimulation of cells to produce pyrogen is a
simple

’off-on'

phenomenon, with, in this case, increasing

numbers of cells to the active state.

One would suspect

that if the complexes were evenly distributed throughout
the culture medium in the flask, cells would be fairly
uniformly exposed to equivalent numbers of complexes.
However,

if an irreversible attachment to the cell surface

or interiorization of the complexes is a prerequisite to
stimulation, then the metabolic state of individual cells
may dictate which ones are activated more raoidly, consuming
or fixing complexes which are then no longer available to
other cells which have not as rapidly interacted with enough
complexes for activation.

Addition of more comolexes

to the system would then allow a greater number of cells to
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be activated.
Some results surest that the cell preparations do not
require continuous stimulation by the complexes for endogenous
pyrogen production to continue.

In a few experiments, the

monocytes were stimulated with complexes, and after 18 hours
of incubation, the supernatant fluid was removed from the
flask and replaced with fresh tissue culture medium.

Rein-

cabation of these cells allowed continued production of
significant amounts of pyrogen even in the absence of the
complexes.

This finding may reflect a fundamental irre¬

versibility to the activated state.

Once activated,

the

cell may be essentially independent of the amount of
stimulating substance present.

It has been shown in

.other

systems that activation of PMNs completelv precedes any
pyrogen oroduction (82).
Comoarison of the data for cell preparations stimulated
with 10 times antigen excess complexes and 50 times antigen
excess comolexes suggests that qualitative differences in
the structure of the complexes may play a role in determin¬
ing their potency as stimulators of pyrogen production.
and Mannik have shown that complexes formed in vivo
and i_n vitro

(75)

(74) are not uniform in size or molecular

antibodv-antigen ratio.

Using human serum albumin

(HSA)

and rabbit antibodies to HSA, they showed that soluble
complexes formed in a mixture of 5 times antigen excess
contained free antibody

(20% of total protein), comolexes

of antibody to antigen of molar ratios of 2:1

(34%),

and

Arend

-
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complexes of larger size comprised of more than 1 antigen
and more than 2 antibodies

(46%)

(75).

A mixture of 20-

times antigen excess complexes contained only 32% large
complexes and more

(48%)

of the small complexes.

In

greater antigen excess there are lesser amounts of large
complexes and increased amounts of small complexes, and
the same in orobably true in our system.
It is clear from our data that the complexes prepared
at 50 times antigen excess are essentially ineffective as
stimuli of monocyte pyrogen production, while complexes
formed at 10 times antigen excess, or 10 times antibody
excess are effective.

Larger complexes, therefore, may be

the active macromolecular moiety in our system, although
this is not proven.
for our findings.

There mav be alternative explanations
Equal volumes of the various complex

mixtures were added to our preparations, in order to
eliminate effects of var^/ing the concentration of the cultur
medium.

Therefore equal volumes of comnlexes of varying

antigen antibody proportions were compared.

Therefore,

5

fold less total antibody was present in the 50-times antigen
excess preparation than in the 10 times antigen excess
preparation

(high dose).

Since, as noted above, there is

some dose relationship) for activation of the cells,

the

observed negative responses at 50 times antigen excess may
be due to inadequate total dose of complexes, when measured
by the antibody moiety, rather than qualitative differences
in complex structure oer se.

However, when complexes were
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preoared at 20-times antigen excess

(data not included in

results because only 8 values were obtained), the average
fever response was only 0,25°C, corresponding to a pyrogen
dose of less than 1,0 units,
complexes did

These 20-times antigen excess

contain amounts of antibody equal to that

present in the low dose 10-times antigen excess complexes,
which were shown to stimulate significant amounts of pyrogen
production

(see Fig,

7),

So while the ineffectiveness of

the 50 times antigen excess complexes may be a result of
dose effects, it appears that qualitative aspects of the
complexes also play a role.
The 50 times antigen excess complexes may be poor
stimuli as a result of the ratio of globulins present, since
in this system the antigen is itself an immunoglobulin.
Although commerciallv preoared BGC probably contains mostly
denatured protein, some intact BGG is probably also present.
If the mechanism bv which complexes stimulate monocytes
is a specific interaction between the Fc region of antibody
in complexes and a specific immunoglobulin receotor on the
ceil surface, then free immunoglobulin may competitively
inhibit the interaction, as is observed in other cell-complex
interactions.
ture,

Free BGG present in the antigen excess mix¬

therefore, may exert an inhibitory effect on the

complex-mediated stimulation of cells.

Arend and Mannik

have shown that there is only partial soecies specificity
for inhibition of cell-complex adherence,

so the exact

effects of free BGG, or even free rabbit antibody, on the

(39)

59

cell-complex interactions in this system are unknown.
Similar mechanisms of competitive binding, and low dose
of complexes may be playing a role in the resoonse observed
with antibody excess complexes.

While they clearly had a

positive stimulating effect on cells, in the amounts given,
the statistical mean of the pyrogen dose produced is lower
than that observed with the same "dose” of 10 times antigen
excess complexes

(1.9 -

.70 pyrogen units compared to 2.3 -

.50 units for antigen excess), although there is some
probability that the statistical means might be in the same
range.

Cells may have, in fact, received a lower dose of

antibody excess complexes.

When preparing complexes in

vitro it was observed that the gross size of the precipitate
pellet was much larger in the antibody excess tube as
compared to the antigen excess precipitate which appeared
minuscule.

So the total dose of complexes present in a

given volume of the antibody excess supernate may well have
been considerably lower than that present in the antigen
excess supernate.

Additionally, if the complex-cell inter¬

action is inhibited by free antibody, then free rabbit
antibodies present in antibody excess mixtures may have had
an inhibitory action of the stimulating effect of the
complexes which were present.

Considered together, this

might indicate that if an active fraction of complexes could
be separated from the total complex mixture, complexes formed
in antibodv excess might,

in fact, be a more potent stimulus

for pyrogen production than complexes formed at antigen
excess.
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That is, a range of larger complexes may be the active
molecular species.

By preparing complexes in antigen excess,

one may be decreasing the total dose of the active molecular
fraction by forming increased amounts of small complexes of
antibody to antigen ratio of 2:1 or less.

These small com¬

plexes may render the small amount of large complexes
ineffective bv directly inhibiting the action of the larger
complexes present, just as does the free BCG.
Quagliata

Phillips-

(46) showed that complexes with monovalent antigens

not only fail to attach to cells, but also markedly inhibit
the attachment of complexes with polyvalent antigen.

Thus,

small complexes present in large amounts in far antigen
excess may represent complexes of functionally monovalent
antigen which are both non-stimulatory themselves, and
inhibitory to the attachment of adequate numbers of the
active,

larger complexes.

Precipitated complexes did not stimulate monocytes to
produce pyrogen in this system, even though they contain
relatively large complexes.

At equivalence, the calculated

antibody to antigen ratio for the precipitated complexes is
approximately 3:1, antibody to antigen; in antibody excess,
complexes of this size or larger are probably present.

In a

similar system, precipitated complexes are readily interiorized by macrophages,
subsequently degraded

localized in ohagolysozomes, and

(33).

It may be argued that perhaps

the cells did not phagocytose the precipitates.

It was not

demonstrated that such phagocytosis in fact took place.

How-
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ever, the cells were clearly capable of phagocytosis of
staph particles and capable of pyrogen production while m
the presence of the precipitates, and mononuclear cells are
known to phagocytize a wide variety of particulate substances
including cellular debris, without a requirement for
opsenizing antibodies.

And the microscopic appearance of

the cells in the presence of precipitates suggested wide¬
spread and extreme cell activation, the cells appearing
grossly enlarged, granular and clumped into large aggre¬
gates.

This corresponded in appearance to that observed

in flasks in which phagocytosis of heat killed staphylo¬
coccal particles had occurred.

So while not proven, it is

suggested that the cells phagocytosed the complex precipitates,
but were not stimulated to produce the pyrogen.
Consequently, although phagocytosis in our system was
not proven, it is likely that the production of pyrogen may
not be simply a nonspecific concomitant of phagocytosis of
particles.
cells

Phagocytic cells are known pyrogen-producing

(1,25,29) and, in general,

greater amounts of pyrogen

are produced in response to larger amounts of phagocytic
stimulus

(1).

There are numerous kinds of particles which

are readily phagocytosed by such cells

(34).

However, many

soluble substances are adequate stimuli also, such as
etiocholanolone

(20), tuberculin

unpublished observations).

(1) and endotoxin

(Bodex,

And since the stimulus for

pyrogen production in the presence of immune complexes is
presumably not phagocytosis per se, a more specific complex-

Hr
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cell interaction must be postulated to account for the
observed stimulation by the complexes in solution.
The most likely mechanism by which complexes stimulate
the cells to pvrogen production may be through specific
attachment to the immunoglobulin receptors on the cell
surface.

In the case of precipitates, such interactions

may be infrequent.

It is well known that the process of

formation of antigen-antibody complex is a two step
process:

first attachment of the antibodies by the Fab

region attaching site, to numerous exposed antigenic deter¬
minants on the antigen molecule.

The process of precipi¬

tation per se is due to noncovalent intermolecular inter¬
actions between numerous such antibodies on one or more
antigens in such a way-that water is excluded from the
complex, and it forms an insoluble precipitate

(84).

So,

in precipitate form,the specific region of the Fc fragment
required for interaction with cells mav be bonded noncovalentlv
to other antibodies and thus unavailable

for attachment to

the specific cell receotor altogether, and/or the combining
site may have too much simple steric interference from
neighboring molecules.

This theory, then, would suggest that

precipitates are probably phagocytized non-specificallv as
particles, whereas soluble complexes interact first with
numerous adjacent cell surface receptors,
activation of the cell processes,

thereby stimulating

including pvrogen production.

Precipitates mav have failed to initiate pvrogen produc¬
tion through alterations in the availability of complement.
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Precipitated complexes, unlike soluble ones, were washed,
removing other rabbit serum factors,and one might question
whether absence of complement was the reason the precipitates
seemed to elicit no pyrogen response.
body fixes human complement

However, rabbit anti¬

(85), and the tissue culture

medium contained 15% fresh human serum, presumably an adequate
source of complement.
Studies of the factors required for activation of mono¬
cytes by soluble complexes were limited.

Several experiments,

however, showed clearly that heating both rabbit and human
sera prevented all activation
tions).

(3odel, unpublished observa¬

This data suggests the importance of complement

to the reaction.
While much literature data on the interaction of complexes
with cells, both in vivo and in_ vitro, has been presented
on the role of complement in such reactions, the exact
role complement plays in this system remains to be defined.
Complement factors may stimulate pyrogen oroduction quite
independently of the actual cell-complex interaction.

This

seems unlikely, since complement fixing precipitates should,
then, activate the cells.

On the other hand, cells may

be activated bv a theoretical cell-comolex interaction
quite independently of a concomitant complement consumotion
reaction.

It has been proposed that in vivo uotake of

large complexes, which fix complement most readily,

is a

phenomenon quite separate from their observed in vitro
complement

fixing abilities

(75),

It has been also suggested

.
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by Mickenberg et al_ (73)

that the pyrogen producing ability

of large complexes formed in antibody excess is a complementindependent phenomenon, since cobra venom factor-treated
rabbits retain febrile reactivity to such complexes, unlike
smaller complexes which are formed in antigen excess.
However, much data supports the view that complement does
play a role in the pathogenesis of immune

fever.

For

example, Mickenberg showed convincingly that complement
depletion eliminated febrile responsiveness to antigen
excess complexes

(73).
a

One hypothesis which might explain the apparently
conflicting results is that complement independent
attachment of soluble complexes to cells in this system
may indeed take place concomitantlv with a probably
comolement dependent mechanism of pyrogen production.
According to this theory, the phenomenon of stimulation of
pyrogen production may be a separate one from that of
attachment and subsequent interiorization by the cell.
It is apparent from our data and from that of others
(73), that there is a finite range of size

(lattice size)

of antigen-antibody complexes which activate mononuclear
cells to produce pyrogen, or cause the release of enzymes
polymorohonuclear leukocytes

(00),

However, Arend and

Mannik have shown that clearance of antigen-antibody
complexes of all sizes from the circulation of animals is
virtuallv complete,
(75).

90 percent being removed by the liver

Clinical evidence suggests that the immunopatholog.ic

.
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activity of complexes is not primarily due to presence of
complexes in the circulation, but rather to abnormal
localization of complexes in sites from which they are not
rapidly cleared, e.g,
blood vessels

in the kidney

(86), in the walls of

(87), in the cerebrospinal fluid space

(88),

This suggests that uptake of complexes from the circulation
by cells of the reticuloendothelial system may not be the
mechanism of pyrogen production.

It may be that separate,

probably complement dependent, interactions take place
between cells and soluble complexes of large size
sedimentation coefficient)

(> 11S

resulting in activation of

mononuclear cells, with the production pyrogen as one
result,
When Mickenberg et al showed that antigen excess com¬
plexes of human serum albumin

(HSA) and rabbit anti-HSA,

lost

their fever producing capability in decomplemented rabbits,
while antibody excess complexes retained fever producing
ability in such animals, they concluded that "large”

com¬

plexes formed in antibody excess produced fever independently
of comnlement, that the in vitro complement fixing ability
of the large complexes only "paralelled”
activity.

their fever producing

They concluded that "small” complexes in the

antigen excess mixture were probably not representative of
the complexes which form when antigen is injected into an
immune animal, and could be disregarded as being responsible
for any fever producing activity oroduced by injection of
the antigen.

However, Arend and Mannik have shown that

large complexes are,

in fact, present in mixtures of 10
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(and greater) times antigen excess.
in Mickenberg’s

Perhaps what happened

(73) experiments is that complexes of

sufficient size, but at the small end of the range of
active complexes oresent in the antigen excess mixture
produced fever by a complement dependent mechanism.

Re¬

peated injections of complexes produced increasing con¬
sumption of complement components to the point where the
smaller, relatively inefficient complement fixing complexes
could no longer activate enough complement sufficiently
rapdily to produce activation of cells.

Similar (partial)

depletion of complement, by treatment with cobra venom
factor, rendered the complexes again incapable of initia¬
ting activation of the host cells to make pyrogen.

However,

when large complexes, at the larger end of the range of
active Comdexes, were injected, their more efficient
comnlement fixing ability allowed them to initiate a
(complement dependent) response even in the face of
(partial)

complement depletion.

Indeed,

further reduction

in complement was observed when the antibody excess complexes
were injected.

That the large complexes consumed less

comdement in vivo,

in a normal animal,

than did antigen

excess complexes, can be accounted for on the basis of
their much shorter life span in the circulation.

Clearance

of complexes by the RES may be what stopped their activity
in stimulating cells to produce pyrogen, rather than what
produced the pyrogen.
Obviously, data is required to deters.' ".e exactly what
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in vitro mechanisms are in fact operating to lead to cell
stimulation.

The theory presented herein accounts for

observed phenomena in Mickenberg’s in vivo system, and is
consistent with the observed data for complex-cell inter¬
actions as well as the present finding that phagocytosis
of complexes per se does not result in pyrogen production.
Coincidentallv it offers a possible theory of febrile
complex tolerance, i.e.

complement depletion, which can

account for complement dependent cell activation to pyrogen
production in the face of complement independent mechanisms
observed in uptake of complexes by macroohages in vitro and
clearance of complexes in vivo.
Similar mechanisms of complement dependent cell activa¬
tion without phagocytosis have been proposed in other systems.
Miller ejt al

(89) have observed complement mediated release

of complexes from lymphocyte surfaces, involving the properdin
pathway of complement activation.

The authors propose that

antigen-antibody induced activation of the normal complement
sequence

leads to attachment of an antigen-antibody-complement

complex to the cell surface.

However, subsequent activation

of the alternate oathway Droduces intermediates which then
cause the release of the complexes, thereby mediating a
possible transient association of antigen-antibody complexes
with the cells, possiblv resulting in some form of cell
activation without concomitant phagocvtosis.

Certainly such

a mechanism is an attractive one for interpretation of the
complex induced cell activation leading to production of
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pyrogen.
Many aspects of immune fever, both experimental and
clinical, remain unclear.

What is the exact nature of the

complex-cell interaction?

Is pyrogen production a necessary

concomitant of attachment and phagocytosis of complexes by
cells of the RES, or can uptake and clearance of complexes
occur without pyrogen production?

What other cells are

capable of being activated by complexes?

Which cells are

the active ones in various hypersensitivity disease states?
Are other mechanisms of cell activation involved?
complement play a role in attachment?
cell activation?

Does

interiorizat.ion?

What mechanisms operate in vivo to result

in defective clearance of complexes and localization of
complexes in sites where they mediate inflammation and
injury?
lators

Exactly what kinds of complexes are active stimu¬
of cells?

What antibody class and subclass

specificity exists for fever production?

What kinds of

naturally occurring exogenous and endogenous antigens are
responsible for observed clinical hypersensitivity states
in which fever is a part of the symptom complex?
Hopefully, further studies using our in vitro system
mav help to answer some of these questions.

When various

molecular species present in a reaction mixture of complexes
are separated, the effectiveness of large and small species
can be directly evaluated.

Further experiments with

decomplemented serum need to be carried cut to determine the
exact complement requirements of the pyrogen production
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phenomenon.

Use of different antigens may help elucidate

mechanisms of fever production in clinical states
associated with antigen-antibody complexes involving host
antigens such as DMA, and glomerular basement membrane.
And much remains to be done to determine the relations
between the mechanisms of immune fever production and those
involved in the pathogenesis of immune complex disease.
SUMMARY
Human peripheral blood monocytes were stimulated rn vitro
by soluble antigen-ar.tibody complexes to produce endogenous
pyrogen,

A dose-deoendent relationship was observed between

pyrogen production and the amount of immune comolexes present
in the medium surrounding the cells.

Qualitative differences

in the size of comolexes were inferred to play a role in
determining the potency of complexes as cell stimulators.
Precipitated antigen-antibody complexes were inactive as
stimuli for pvrogen production.

Theories of in vivo immune

fever production are oroposed, on the basis of the present
findings.

.
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